Cargando…

Clinical and Functional Outcomes After 2 Years in the Early Detection and Intervention for the Prevention of Psychosis Multisite Effectiveness Trial

OBJECTIVE: To test effectiveness of the Early Detection, Intervention, and Prevention of Psychosis Program in preventing the onset of severe psychosis and improving functioning in a national sample of at-risk youth. METHODS: In a risk-based allocation study design, 337 youth (age 12–25) at risk of p...

Descripción completa

Detalles Bibliográficos
Autores principales: McFarlane, William R., Levin, Bruce, Travis, Lori, Lucas, F. Lee, Lynch, Sarah, Verdi, Mary, Williams, Deanna, Adelsheim, Steven, Calkins, Roderick, Carter, Cameron S., Cornblatt, Barbara, Taylor, Stephan F., Auther, Andrea M., McFarland, Bentson, Melton, Ryan, Migliorati, Margaret, Niendam, Tara, Ragland, J. Daniel, Sale, Tamara, Salvador, Melina, Spring, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266296/
https://www.ncbi.nlm.nih.gov/pubmed/25065017
http://dx.doi.org/10.1093/schbul/sbu108
_version_ 1782349004583993344
author McFarlane, William R.
Levin, Bruce
Travis, Lori
Lucas, F. Lee
Lynch, Sarah
Verdi, Mary
Williams, Deanna
Adelsheim, Steven
Calkins, Roderick
Carter, Cameron S.
Cornblatt, Barbara
Taylor, Stephan F.
Auther, Andrea M.
McFarland, Bentson
Melton, Ryan
Migliorati, Margaret
Niendam, Tara
Ragland, J. Daniel
Sale, Tamara
Salvador, Melina
Spring, Elizabeth
author_facet McFarlane, William R.
Levin, Bruce
Travis, Lori
Lucas, F. Lee
Lynch, Sarah
Verdi, Mary
Williams, Deanna
Adelsheim, Steven
Calkins, Roderick
Carter, Cameron S.
Cornblatt, Barbara
Taylor, Stephan F.
Auther, Andrea M.
McFarland, Bentson
Melton, Ryan
Migliorati, Margaret
Niendam, Tara
Ragland, J. Daniel
Sale, Tamara
Salvador, Melina
Spring, Elizabeth
author_sort McFarlane, William R.
collection PubMed
description OBJECTIVE: To test effectiveness of the Early Detection, Intervention, and Prevention of Psychosis Program in preventing the onset of severe psychosis and improving functioning in a national sample of at-risk youth. METHODS: In a risk-based allocation study design, 337 youth (age 12–25) at risk of psychosis were assigned to treatment groups based on severity of positive symptoms. Those at clinically higher risk (CHR) or having an early first episode of psychosis (EFEP) were assigned to receive Family-aided Assertive Community Treatment (FACT); those at clinically lower risk (CLR) were assigned to receive community care. Between-groups differences on outcome variables were adjusted statistically according to regression-discontinuity procedures and evaluated using the Global Test Procedure that combined all symptom and functional measures. RESULTS: A total of 337 young people (mean age: 16.6) were assigned to the treatment group (CHR + EFEP, n = 250) or comparison group (CLR, n = 87). On the primary variable, positive symptoms, after 2 years FACT, were superior to community care (2 df, p < .0001) for both CHR (p = .0034) and EFEP (p < .0001) subgroups. Rates of conversion (6.3% CHR vs 2.3% CLR) and first negative event (25% CHR vs 22% CLR) were low but did not differ. FACT was superior in the Global Test (p = .0007; p = .024 for CHR and p = .0002 for EFEP, vs CLR) and in improvement in participation in work and school (p = .025). CONCLUSION: FACT is effective in improving positive, negative, disorganized and general symptoms, Global Assessment of Functioning, work and school participation and global outcome in youth at risk for, or experiencing very early, psychosis.
format Online
Article
Text
id pubmed-4266296
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-42662962014-12-19 Clinical and Functional Outcomes After 2 Years in the Early Detection and Intervention for the Prevention of Psychosis Multisite Effectiveness Trial McFarlane, William R. Levin, Bruce Travis, Lori Lucas, F. Lee Lynch, Sarah Verdi, Mary Williams, Deanna Adelsheim, Steven Calkins, Roderick Carter, Cameron S. Cornblatt, Barbara Taylor, Stephan F. Auther, Andrea M. McFarland, Bentson Melton, Ryan Migliorati, Margaret Niendam, Tara Ragland, J. Daniel Sale, Tamara Salvador, Melina Spring, Elizabeth Schizophr Bull Regular Article OBJECTIVE: To test effectiveness of the Early Detection, Intervention, and Prevention of Psychosis Program in preventing the onset of severe psychosis and improving functioning in a national sample of at-risk youth. METHODS: In a risk-based allocation study design, 337 youth (age 12–25) at risk of psychosis were assigned to treatment groups based on severity of positive symptoms. Those at clinically higher risk (CHR) or having an early first episode of psychosis (EFEP) were assigned to receive Family-aided Assertive Community Treatment (FACT); those at clinically lower risk (CLR) were assigned to receive community care. Between-groups differences on outcome variables were adjusted statistically according to regression-discontinuity procedures and evaluated using the Global Test Procedure that combined all symptom and functional measures. RESULTS: A total of 337 young people (mean age: 16.6) were assigned to the treatment group (CHR + EFEP, n = 250) or comparison group (CLR, n = 87). On the primary variable, positive symptoms, after 2 years FACT, were superior to community care (2 df, p < .0001) for both CHR (p = .0034) and EFEP (p < .0001) subgroups. Rates of conversion (6.3% CHR vs 2.3% CLR) and first negative event (25% CHR vs 22% CLR) were low but did not differ. FACT was superior in the Global Test (p = .0007; p = .024 for CHR and p = .0002 for EFEP, vs CLR) and in improvement in participation in work and school (p = .025). CONCLUSION: FACT is effective in improving positive, negative, disorganized and general symptoms, Global Assessment of Functioning, work and school participation and global outcome in youth at risk for, or experiencing very early, psychosis. Oxford University Press 2015-01 2014-07-26 /pmc/articles/PMC4266296/ /pubmed/25065017 http://dx.doi.org/10.1093/schbul/sbu108 Text en © The Author 2014. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Regular Article
McFarlane, William R.
Levin, Bruce
Travis, Lori
Lucas, F. Lee
Lynch, Sarah
Verdi, Mary
Williams, Deanna
Adelsheim, Steven
Calkins, Roderick
Carter, Cameron S.
Cornblatt, Barbara
Taylor, Stephan F.
Auther, Andrea M.
McFarland, Bentson
Melton, Ryan
Migliorati, Margaret
Niendam, Tara
Ragland, J. Daniel
Sale, Tamara
Salvador, Melina
Spring, Elizabeth
Clinical and Functional Outcomes After 2 Years in the Early Detection and Intervention for the Prevention of Psychosis Multisite Effectiveness Trial
title Clinical and Functional Outcomes After 2 Years in the Early Detection and Intervention for the Prevention of Psychosis Multisite Effectiveness Trial
title_full Clinical and Functional Outcomes After 2 Years in the Early Detection and Intervention for the Prevention of Psychosis Multisite Effectiveness Trial
title_fullStr Clinical and Functional Outcomes After 2 Years in the Early Detection and Intervention for the Prevention of Psychosis Multisite Effectiveness Trial
title_full_unstemmed Clinical and Functional Outcomes After 2 Years in the Early Detection and Intervention for the Prevention of Psychosis Multisite Effectiveness Trial
title_short Clinical and Functional Outcomes After 2 Years in the Early Detection and Intervention for the Prevention of Psychosis Multisite Effectiveness Trial
title_sort clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266296/
https://www.ncbi.nlm.nih.gov/pubmed/25065017
http://dx.doi.org/10.1093/schbul/sbu108
work_keys_str_mv AT mcfarlanewilliamr clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT levinbruce clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT travislori clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT lucasflee clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT lynchsarah clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT verdimary clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT williamsdeanna clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT adelsheimsteven clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT calkinsroderick clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT cartercamerons clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT cornblattbarbara clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT taylorstephanf clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT autherandream clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT mcfarlandbentson clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT meltonryan clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT miglioratimargaret clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT niendamtara clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT raglandjdaniel clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT saletamara clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT salvadormelina clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial
AT springelizabeth clinicalandfunctionaloutcomesafter2yearsintheearlydetectionandinterventionforthepreventionofpsychosismultisiteeffectivenesstrial